Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
07/2002
07/16/2002US6420606 Alkylation in the presence of base and solvent, deprotection aminoaryl ether
07/16/2002US6420586 Amino acid-derived cyclic phosphonamides and methods of synthesizing the same
07/16/2002US6420561 Piperazinyl or piperidinyl acid derivatives for treatment of rheumatic diseases, arthritis due to gout and antiinflammatory agents
07/16/2002US6419711 Oxidation dyeing compositions containing a cationic coupling agent, novel cationic coupling agents
07/11/2002WO2002024632A3 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
07/11/2002WO2000073263A9 Cytofectin dimers and methods of use thereof
07/11/2002US20020091287 Process for separating the diastereomeric bases of 2-[(Dimethylamino)methyl] -1-(3-methoxyphenyl) cylohexanol
07/10/2002EP1221441A2 LTA4 Hydrolase inhibitors
07/10/2002EP1220831A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors
07/10/2002CN1358169A N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
07/09/2002US6417401 Ether diamines amine oxides
07/09/2002US6417353 Preparing amines
07/09/2002US6417162 Female impotence treated with heterocyclic compound containing nitro groups
07/09/2002CA2222275C Fluorinated xanthene derivatives
07/09/2002CA2217455C New substituted derivatives, of biphenyl or phenylpiridine, their preparation process and the pharmaceutical compositions that contain them
07/04/2002WO2002051909A1 Diamines, polyimide precursors and polyimides produced by using the diamines, and liquid crystal aligning agents
07/04/2002WO2002051908A1 Diaminobenzene derivatives, polyimide precursors and polyimides prepared by using tha same, and liquid crystal aligning agents
07/04/2002WO2002051793A1 Sterol isomerase inhibitors
07/04/2002US20020086904 Methods of treating affective disorders using derivatives of (-)- venlafaxine
07/04/2002US20020086884 Anticancer agents based on regulation of protein prenylation
07/04/2002US20020083804 Removal tool for locking nut, bolt and clip systems and assemblies
07/04/2002DE10065442A1 Verbessertes Verfahren zur Herstellung von 2-(4-Trifluormethoxyphenyl)-ethylamin und von 4-Brommethyl- und 4-Chlormethyl-1-trifluormethoxy-benzol An improved process for the preparation of 2- (4-trifluoromethoxyphenyl) ethylamine and 4-bromomethyl- and 4-chloromethyl-1-trifluoromethoxy-benzene
07/03/2002EP1219597A1 Process for production of ether amine
07/03/2002EP1219591A1 Process for preparing 2-(4-trifluoromethoxyphenyl)ethylamine and 4-bromomethyl- and 4-chloromethyl- -1trifluoromethoxybenzene
07/03/2002EP1218336A2 Melanin concentrating hormone antagonist
07/03/2002EP1077912B1 Novel derivatives of 3,3-diphenylpropylamines
07/03/2002EP1037871B1 Novel antiarrhythmic compounds
07/03/2002CN1356989A Substituted herbicidal phenyluracils
07/02/2002US6414179 Useful agents in the treatment of inflammatory diseases such as asthma, arthritis, inflammatory bowel disease and neurodegenerative diseases
06/2002
06/27/2002WO2002050077A2 Triazolopyrimidines
06/27/2002WO2002050017A1 Process for the preparation of phenethylamine derivatives
06/27/2002US20020082454 Process for preparing 2-(4-trifluoromethoxyphenyl)ethylamine and 4-bromomethyl-and 4-chloromethyl-1-trifluoromethoxybenzene
06/27/2002DE10063115A1 Triazolopyrimidine Triazolopyrimidines
06/26/2002EP1216994A2 Tricyclic antidepressant derivatives and immunoassay
06/26/2002EP1216223A1 Novel dicarboxylic acid derivatives with pharmaceutical properties
06/26/2002CN1355782A Benzene derivatives, preparation method and pharmaceutical compositions containing same
06/25/2002US6410794 Resolution racemic mixtures
06/25/2002US6410790 Analgesics
06/25/2002US6410787 Process to prepare 2-aminoindan derivatives
06/25/2002US6410736 Biaryl ether derivatives useful as monoamine reuptake inhibitors
06/25/2002US6410564 Naphthyl compounds, intermediates, processes, compositions, and methods
06/25/2002US6409773 Aminophenol couplers
06/25/2002CA2099586C Drug material suitable for micronisation
06/23/2002CA2365803A1 Catalyst and process for preparing low-viscosity and color-reduced polyisocyanates containing isocyanurate groups
06/20/2002WO2002048123A2 Process for the preparation of morpholinones
06/20/2002WO2002048078A1 2-butyl-3-(4-[3(dibutylamino)propoxy]benzoyl)-5-nitro-benzofuran hydrochloride and preparation thereof
06/20/2002WO2002047635A1 Novel coupler for use in oxidative hair dyeing
06/20/2002WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands
06/20/2002WO2002004386A3 Alkoxylated tertiary and quaternary amine surfactants
06/20/2002DE10062729A1 Verfahren zur Racemisierung von optisch aktiven Aminen A process for the racemization of optically active amines
06/20/2002CA2428186A1 Novel coupler for use in oxidative hair dyeing
06/19/2002EP1215197A2 Method for the racemisation of optically active amines
06/19/2002EP1215196A1 Selective reductive amination of nitriles
06/19/2002EP0973725B1 New 1,7,7-trimethyl-bicyclo 2.2.1]heptane derivatives
06/19/2002CN1354737A Novel derivatives of 3-3-diphenylpropylamines
06/19/2002CN1086381C Process for preparation of alkynyl oxy-methylamine and its quaternary amine salt and corrosion inhibitor
06/18/2002US6407127 3-(4-(2-(5h-dibenzo(a,d)cyclohepten-5-yloxy)-ethoxyl-phenyl)-2 -ethoxy-propionic acid ethyl ester as antidiabetic agents and to treat obesity
06/18/2002US6407099 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
06/13/2002WO2002046140A1 Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation
06/13/2002WO2002046139A2 1,7 and 1,9-diarylpolymethine salts
06/13/2002WO2002045658A2 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
06/13/2002WO2002018334A3 Sodium channel modulators
06/13/2002WO2002008219A3 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
06/13/2002US20020072632 Catalyst ligands, catalytic metal complexes and processes using same
06/13/2002US20020072529 For therapy and prophylaxis of cerebral apoplexy and craniocerebral trauma
06/13/2002CA2426158A1 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
06/12/2002EP1213279A1 Venlafaxine production process
06/12/2002EP0938467B1 Process for the preparation of optically pure isomers of formoterol
06/12/2002EP0894787B1 3,4-disubstituted phenylethanolaminotetralincarboxylate derivatives
06/12/2002CN1353687A High purity (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof
06/12/2002CN1353686A Process for preparing (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof
06/11/2002US6403834 Method for preparing tris(ether-amine)
06/11/2002US6403832 Mixing acid with amine, precipitating salt, and filtering; good optical purity
06/11/2002US6403577 Hexamethyleneiminyl tachykinin receptor antagonists
06/06/2002WO2002044127A1 Substituted carboxylic acid derivatives
06/06/2002WO2002044120A1 Compounds active at the glucocorticoid receptor iii
06/06/2002US20020068839 Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
06/06/2002US20020068765 8,9-dihydro-7H-benzocycloheptene derivatives are useful for phophylaxis and therapy of osteoporosis(have selective estrogenic activity on bones)
06/06/2002US20020068750 Mitochondria protecting agents for treating mitochondria associated diseases
06/06/2002US20020068736 Biphenyl compounds and their use as oestrogenic agents
06/05/2002EP1211301A1 Organic electroluminescent device
06/05/2002EP1003719B1 Microbicidal n-sulfonylglycin alkynyloxyphenemethyl amide derivatives
06/05/2002EP0883599B1 Aminotetralin derivatives and compositions and method of use thereof
06/05/2002EP0711282B1 Compounds as pde iv and tnf inhibitors
06/05/2002CN1352629A Method for the recemization of optically active amines
06/04/2002US6399830 Using catalyst
06/04/2002US6399829 Salt formation using hydrogen chloride in presence ot toluene; crystallization in nitrile solvent
06/04/2002US6399827 Quaternary ammonium phosphate compound and method of preparing same
06/04/2002US6399663 Drug delivery
06/04/2002US6399660 Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis
06/04/2002US6399272 Phenylenediamine derivative-type additive useful for a chemically amplified photoresist
05/2002
05/30/2002WO2002042259A2 Methods of synthesizing and using derivatives of [2-(2-aminoethoxy)ethoxy] acetic acid
05/30/2002WO2002042248A2 Naphthalene derivatives
05/30/2002US20020065312 Aminotetralins as 5-HT1Dalpha agonists
05/30/2002US20020065299 Administering for therapy of mitochondria medited disease
05/30/2002US20020065298 Mitochondria protecting agents for treating mitochondria associated diseases
05/30/2002US20020065278 Non-imidazole aryloxyalkylamines
05/30/2002US20020065251 Quaternary ammonium phosphate compound is formed by reacting quaternary ammonium hydroxide containing methylbenzene group with phosphoric acid, which acts as anticorrosive and microbiocide
05/30/2002US20020065246 Useful agents in the treatment of inflammatory diseases such as asthma, arthritis, inflammatory bowel disease and neurodegenerative diseases
05/29/2002EP1209185A1 Diaminobenzene derivative, polyimide obtained therefrom, and liquid-crystal alignment film
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 140